Godavari Drugs Limited (BOM:530317)
125.18
+15.31 (13.93%)
At close: Sep 25, 2026
Godavari Drugs Market Cap
Godavari Drugs has a market cap or net worth of 1.27 billion as of September 25, 2026. Its market cap has increased by 102.71% in one year.
Market Cap
1.27B
Enterprise Value
1.89B
Revenue
1.11B
Ranking
n/a
PE Ratio
24.88
Stock Price
125.18
ChartMarket Cap Chart
Since April 30, 2001, Godavari Drugs's market cap has increased from 15.34M to 1.27B, an increase of 8,162.73%. That is a compound annual growth rate of 18.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.27B | 119.12% |
| Dec 31, 2025 | 578.57M | -29.74% |
| Dec 31, 2024 | 823.46M | 21.42% |
| Dec 29, 2023 | 678.20M | -5.10% |
| Dec 30, 2022 | 714.64M | 51.48% |
| Dec 31, 2021 | 471.79M | 79.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bal Pharma | 1.67B |
| Parnax Lab | 1.41B |
| Lactose (India) | 1.38B |
| Speciality Medicines | 1.30B |
| Aayush Wellness | 1.18B |
| Makers Laboratories | 1.10B |
| Asston Pharmaceuticals | 1.06B |
| Pharmaids Pharmaceuticals | 1.05B |